BindingDB logo
myBDB logout

Patent code US10385031

Compile Data Set for Download or QSAR
Found 171 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411333
PNG
(US10385031, Compound 039)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5OS2/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)18-21-11-16(26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411335
PNG
(US10385031, Compound 041)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C19H21N5OS2/c1-12-19(24-8-6-21-7-9-24)27-18(22-12)17(25)23-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-11,21H,6-9,20H2,1H3,(H,23,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411337
PNG
(US10385031, Compound 043)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C19H21N5O2S/c1-12-19(24-7-5-21-6-8-24)27-18(22-12)17(25)23-16-10-13(2-3-15(16)20)14-4-9-26-11-14/h2-4,9-11,21H,5-8,20H2,1H3,(H,23,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411344
PNG
(US10385031, Compound 050)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)18-21-11-16(26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411347
PNG
(US10385031, Compound 053)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)20-24-12-18(28-20)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411360
PNG
(US10385031, Compound 066)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C19H20N4O2S/c20-15-2-1-13(14-5-10-25-12-14)11-16(15)22-19(24)17-3-4-18(26-17)23-8-6-21-7-9-23/h1-5,10-12,21H,6-9,20H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411373
PNG
(US10385031, Compound 079)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H25N5O/c1-27-11-13-28(14-12-27)19-8-10-21(25-16-19)23(29)26-22-15-18(7-9-20(22)24)17-5-3-2-4-6-17/h2-10,15-16H,11-14,24H2,1H3,(H,26,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411328
PNG
(US10385031, Compound 034)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)16-11-21-18(26-16)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411331
PNG
(US10385031, Compound 037)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)18-12-24-20(28-18)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411345
PNG
(US10385031, Compound 051)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-11-13)9-15(14)22-17(24)18-21-10-16(26-18)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411346
PNG
(US10385031, Compound 052)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C19H20N6OS/c20-15-2-1-14(13-3-5-21-6-4-13)11-16(15)24-18(26)19-23-12-17(27-19)25-9-7-22-8-10-25/h1-6,11-12,22H,7-10,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411362
PNG
(US10385031, Compound 068)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C21H21FN4OS/c22-16-4-1-14(2-5-16)15-3-6-17(23)18(13-15)25-21(27)19-7-8-20(28-19)26-11-9-24-10-12-26/h1-8,13,24H,9-12,23H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411377
PNG
(US10385031, Compound 083)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C21H23N5O2/c1-25-7-9-26(10-8-25)17-3-5-19(23-13-17)21(27)24-20-12-15(2-4-18(20)22)16-6-11-28-14-16/h2-6,11-14H,7-10,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411380
PNG
(US10385031, Compound 086)
Show SMILES CN1CCN(CC1)c1cnc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C20H22N6OS/c1-25-6-8-26(9-7-25)19-13-22-17(12-23-19)20(27)24-16-11-14(4-5-15(16)21)18-3-2-10-28-18/h2-5,10-13H,6-9,21H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411381
PNG
(US10385031, Compound 087)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C19H20N6O2/c20-14-4-3-13(17-2-1-9-27-17)10-15(14)24-19(26)16-11-23-18(12-22-16)25-7-5-21-6-8-25/h1-4,9-12,21H,5-8,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411384
PNG
(US10385031, Compound 090)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C21H21FN6O/c22-16-4-1-14(2-5-16)15-3-6-17(23)18(11-15)27-21(29)19-12-26-20(13-25-19)28-9-7-24-8-10-28/h1-6,11-13,24H,7-10,23H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411329
PNG
(US10385031, Compound 035)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc2nc(ccc2c1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C26H24FN5O/c27-21-6-1-17(2-7-21)18-3-8-22(28)24(16-18)31-26(33)20-4-9-23-19(15-20)5-10-25(30-23)32-13-11-29-12-14-32/h1-10,15-16,29H,11-14,28H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411332
PNG
(US10385031, Compound 038)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C22H22FN5O/c23-17-4-1-15(2-5-17)16-3-7-19(24)21(13-16)27-22(29)20-8-6-18(14-26-20)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411334
PNG
(US10385031, Compound 040)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C19H20N6OS/c20-14-4-3-13(17-2-1-9-27-17)10-15(14)24-19(26)16-11-23-18(12-22-16)25-7-5-21-6-8-25/h1-4,9-12,21H,5-8,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411341
PNG
(US10385031, Compound 047 | US10385031, Compound 04...)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5OS/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411361
PNG
(US10385031, Compound 067)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C20H21N5OS/c21-16-2-1-15(14-5-7-22-8-6-14)13-17(16)24-20(26)18-3-4-19(27-18)25-11-9-23-10-12-25/h1-8,13,23H,9-12,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411370
PNG
(US10385031, Compound 076)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccccc1F
Show InChI InChI=1S/C22H22FN5O/c23-18-4-2-1-3-17(18)15-5-7-19(24)20(13-15)27-22(29)16-6-8-21(26-14-16)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411334
PNG
(US10385031, Compound 040)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C19H20N6OS/c20-14-4-3-13(17-2-1-9-27-17)10-15(14)24-19(26)16-11-23-18(12-22-16)25-7-5-21-6-8-25/h1-4,9-12,21H,5-8,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411342
PNG
(US10385031, Compound 048)
Show SMILES CN1CCN(CC1)c1ncc(s1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C21H23N5OS/c1-25-9-11-26(12-10-25)21-23-14-19(28-21)20(27)24-18-13-16(7-8-17(18)22)15-5-3-2-4-6-15/h2-8,13-14H,9-12,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411333
PNG
(US10385031, Compound 039)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5OS2/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)18-21-11-16(26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411359
PNG
(US10385031, Compound 065)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C19H20N4O2S/c20-14-4-3-13(16-2-1-11-25-16)12-15(14)22-19(24)17-5-6-18(26-17)23-9-7-21-8-10-23/h1-6,11-12,21H,7-10,20H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411369
PNG
(US10385031, Compound 075)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C21H23N5O2/c1-25-7-9-26(10-8-25)20-5-3-16(13-23-20)21(27)24-19-12-15(2-4-18(19)22)17-6-11-28-14-17/h2-6,11-14H,7-10,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411376
PNG
(US10385031, Compound 082)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C21H23N5O2/c1-25-8-10-26(11-9-25)16-5-7-18(23-14-16)21(27)24-19-13-15(4-6-17(19)22)20-3-2-12-28-20/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411380
PNG
(US10385031, Compound 086)
Show SMILES CN1CCN(CC1)c1cnc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C20H22N6OS/c1-25-6-8-26(9-7-25)19-13-22-17(12-23-19)20(27)24-16-11-14(4-5-15(16)21)18-3-2-10-28-18/h2-5,10-13H,6-9,21H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411345
PNG
(US10385031, Compound 051)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-11-13)9-15(14)22-17(24)18-21-10-16(26-18)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411358
PNG
(US10385031, Compound 064)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N4OS/c22-17-7-6-16(15-4-2-1-3-5-15)14-18(17)24-21(26)19-8-9-20(27-19)25-12-10-23-11-13-25/h1-9,14,23H,10-13,22H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411365
PNG
(US10385031, Compound 071)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C21H23N5OS/c1-25-8-10-26(11-9-25)20-7-5-16(14-23-20)21(27)24-18-13-15(4-6-17(18)22)19-3-2-12-28-19/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411382
PNG
(US10385031, Compound 088)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C19H20N6O2/c20-15-2-1-13(14-3-8-27-12-14)9-16(15)24-19(26)17-10-23-18(11-22-17)25-6-4-21-5-7-25/h1-3,8-12,21H,4-7,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411330
PNG
(US10385031, Compound 036)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C22H22FN5O/c23-18-5-1-15(2-6-18)16-3-7-19(24)20(13-16)27-22(29)17-4-8-21(26-14-17)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411336
PNG
(US10385031, Compound 042)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C19H21N5O2S/c1-12-19(24-8-6-21-7-9-24)27-18(22-12)17(25)23-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-11,21H,6-9,20H2,1H3,(H,23,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411340
PNG
(US10385031, Compound 046)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-11-13)9-15(14)22-17(24)16-10-21-18(26-16)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411348
PNG
(US10385031, Compound 054)
Show SMILES CN1CCN(CC1)c1cnc(s1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C19H21N5O2S/c1-23-6-8-24(9-7-23)17-12-21-19(27-17)18(25)22-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-12H,6-9,20H2,1H3,(H,22,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411364
PNG
(US10385031, Compound 070)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H25N5O/c1-27-11-13-28(14-12-27)22-10-8-19(16-25-22)23(29)26-21-15-18(7-9-20(21)24)17-5-3-2-4-6-17/h2-10,15-16H,11-14,24H2,1H3,(H,26,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411374
PNG
(US10385031, Compound 080)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C21H23N5OS/c1-25-8-10-26(11-9-25)16-5-7-18(23-14-16)21(27)24-19-13-15(4-6-17(19)22)20-3-2-12-28-20/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411341
PNG
(US10385031, Compound 047 | US10385031, Compound 04...)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5OS/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411347
PNG
(US10385031, Compound 053)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)20-24-12-18(28-20)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411368
PNG
(US10385031, Compound 074)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C21H23N5O2/c1-25-8-10-26(11-9-25)20-7-5-16(14-23-20)21(27)24-18-13-15(4-6-17(18)22)19-3-2-12-28-19/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411374
PNG
(US10385031, Compound 080)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C21H23N5OS/c1-25-8-10-26(11-9-25)16-5-7-18(23-14-16)21(27)24-19-13-15(4-6-17(19)22)20-3-2-12-28-20/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411379
PNG
(US10385031, Compound 085)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N6O/c22-17-7-6-16(15-4-2-1-3-5-15)12-18(17)26-21(28)19-13-25-20(14-24-19)27-10-8-23-9-11-27/h1-7,12-14,23H,8-11,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411355
PNG
(US10385031, Compound 061)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O3/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)16-11-21-18(26-16)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411356
PNG
(US10385031, Compound 062)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5O2/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411357
PNG
(US10385031, Compound 063)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5O2/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)18-12-24-20(28-18)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411363
PNG
(US10385031, Compound 069)
Show SMILES Nc1ccc(cc1NC(=O)c1cc(cs1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N4OS/c22-18-7-6-16(15-4-2-1-3-5-15)12-19(18)24-21(26)20-13-17(14-27-20)25-10-8-23-9-11-25/h1-7,12-14,23H,8-11,22H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411378
PNG
(US10385031, Compound 084)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1cc(F)cc(F)c1
Show InChI InChI=1S/C22H21F2N5O/c23-16-9-15(10-17(24)12-16)14-1-3-19(25)21(11-14)28-22(30)20-4-2-18(13-27-20)29-7-5-26-6-8-29/h1-4,9-13,26H,5-8,25H2,(H,28,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411342
PNG
(US10385031, Compound 048)
Show SMILES CN1CCN(CC1)c1ncc(s1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C21H23N5OS/c1-25-9-11-26(12-10-25)21-23-14-19(28-21)20(27)24-18-13-16(7-8-17(18)22)15-5-3-2-4-6-15/h2-8,13-14H,9-12,22H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411349
PNG
(US10385031, Compound 055)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)21-17(24)18-22-16(11-26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,21,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411355
PNG
(US10385031, Compound 061)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O3/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)16-11-21-18(26-16)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411341
PNG
(US10385031, Compound 047 | US10385031, Compound 04...)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5OS/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411353
PNG
(US10385031, Compound 059)
Show SMILES Nc1ccc(cc1NC(=O)c1csc(n1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5OS2/c19-13-4-3-12(16-2-1-9-25-16)10-14(13)21-17(24)15-11-26-18(22-15)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,21,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411354
PNG
(US10385031, Compound 060)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(16-2-1-9-26-16)10-14(13)22-17(24)15-11-21-18(25-15)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411356
PNG
(US10385031, Compound 062)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5O2/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411357
PNG
(US10385031, Compound 063)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5O2/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)18-12-24-20(28-18)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411372
PNG
(US10385031, Compound 078)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cc(F)cc(F)c1
Show InChI InChI=1S/C22H21F2N5O/c23-17-9-16(10-18(24)12-17)14-1-3-19(25)20(11-14)28-22(30)15-2-4-21(27-13-15)29-7-5-26-6-8-29/h1-4,9-13,26H,5-8,25H2,(H,28,30)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411354
PNG
(US10385031, Compound 060)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(16-2-1-9-26-16)10-14(13)22-17(24)15-11-21-18(25-15)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411357
PNG
(US10385031, Compound 063)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5O2/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)18-12-24-20(28-18)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411354
PNG
(US10385031, Compound 060)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(16-2-1-9-26-16)10-14(13)22-17(24)15-11-21-18(25-15)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411356
PNG
(US10385031, Compound 062)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5O2/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411350
PNG
(US10385031, Compound 056)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-10-13)9-15(14)21-17(24)18-22-16(11-26-18)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,21,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411372
PNG
(US10385031, Compound 078)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cc(F)cc(F)c1
Show InChI InChI=1S/C22H21F2N5O/c23-17-9-16(10-18(24)12-17)14-1-3-19(25)20(11-14)28-22(30)15-2-4-21(27-13-15)29-7-5-26-6-8-29/h1-4,9-13,26H,5-8,25H2,(H,28,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411378
PNG
(US10385031, Compound 084)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1cc(F)cc(F)c1
Show InChI InChI=1S/C22H21F2N5O/c23-16-9-15(10-17(24)12-16)14-1-3-19(25)21(11-14)28-22(30)20-4-2-18(13-27-20)29-7-5-26-6-8-29/h1-4,9-13,26H,5-8,25H2,(H,28,30)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411337
PNG
(US10385031, Compound 043)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C19H21N5O2S/c1-12-19(24-7-5-21-6-8-24)27-18(22-12)17(25)23-16-10-13(2-3-15(16)20)14-4-9-26-11-14/h2-4,9-11,21H,5-8,20H2,1H3,(H,23,25)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411351
PNG
(US10385031, Compound 057)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C19H20N6OS/c20-15-2-1-14(13-3-5-21-6-4-13)11-16(15)23-18(26)19-24-17(12-27-19)25-9-7-22-8-10-25/h1-6,11-12,22H,7-10,20H2,(H,23,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411367
PNG
(US10385031, Compound 073)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C21H22N6O/c22-17-6-4-15(18-3-1-2-8-24-18)13-19(17)26-21(28)16-5-7-20(25-14-16)27-11-9-23-10-12-27/h1-8,13-14,23H,9-12,22H2,(H,26,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411378
PNG
(US10385031, Compound 084)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1cc(F)cc(F)c1
Show InChI InChI=1S/C22H21F2N5O/c23-16-9-15(10-17(24)12-16)14-1-3-19(25)21(11-14)28-22(30)20-4-2-18(13-27-20)29-7-5-26-6-8-29/h1-4,9-13,26H,5-8,25H2,(H,28,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411338
PNG
(US10385031, Compound 044)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C19H20N6OS/c20-14-5-4-13(15-3-1-2-6-22-15)11-16(14)24-18(26)17-12-23-19(27-17)25-9-7-21-8-10-25/h1-6,11-12,21H,7-10,20H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411349
PNG
(US10385031, Compound 055)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)21-17(24)18-22-16(11-26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,21,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411351
PNG
(US10385031, Compound 057)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C19H20N6OS/c20-15-2-1-14(13-3-5-21-6-4-13)11-16(15)23-18(26)19-24-17(12-27-19)25-9-7-22-8-10-25/h1-6,11-12,22H,7-10,20H2,(H,23,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411375
PNG
(US10385031, Compound 081)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C21H22N6O/c22-17-6-4-15(18-3-1-2-8-24-18)13-20(17)26-21(28)19-7-5-16(14-25-19)27-11-9-23-10-12-27/h1-8,13-14,23H,9-12,22H2,(H,26,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411355
PNG
(US10385031, Compound 061)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(o1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O3/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)16-11-21-18(26-16)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a>500n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411370
PNG
(US10385031, Compound 076)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccccc1F
Show InChI InChI=1S/C22H22FN5O/c23-18-4-2-1-3-17(18)15-5-7-19(24)20(13-15)27-22(29)16-6-8-21(26-14-16)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411382
PNG
(US10385031, Compound 088)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C19H20N6O2/c20-15-2-1-13(14-3-8-27-12-14)9-16(15)24-19(26)17-10-23-18(11-22-17)25-6-4-21-5-7-25/h1-3,8-12,21H,4-7,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411328
PNG
(US10385031, Compound 034)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)16-11-21-18(26-16)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411332
PNG
(US10385031, Compound 038)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C22H22FN5O/c23-17-4-1-15(2-5-17)16-3-7-19(24)21(13-16)27-22(29)20-8-6-18(14-26-20)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411333
PNG
(US10385031, Compound 039)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5OS2/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)18-21-11-16(26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411334
PNG
(US10385031, Compound 040)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C19H20N6OS/c20-14-4-3-13(17-2-1-9-27-17)10-15(14)24-19(26)16-11-23-18(12-22-16)25-7-5-21-6-8-25/h1-4,9-12,21H,5-8,20H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411336
PNG
(US10385031, Compound 042)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C19H21N5O2S/c1-12-19(24-8-6-21-7-9-24)27-18(22-12)17(25)23-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-11,21H,6-9,20H2,1H3,(H,23,25)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411342
PNG
(US10385031, Compound 048)
Show SMILES CN1CCN(CC1)c1ncc(s1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C21H23N5OS/c1-25-9-11-26(12-10-25)21-23-14-19(28-21)20(27)24-18-13-16(7-8-17(18)22)15-5-3-2-4-6-15/h2-8,13-14H,9-12,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411353
PNG
(US10385031, Compound 059)
Show SMILES Nc1ccc(cc1NC(=O)c1csc(n1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5OS2/c19-13-4-3-12(16-2-1-9-25-16)10-14(13)21-17(24)15-11-26-18(22-15)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,21,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411360
PNG
(US10385031, Compound 066)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C19H20N4O2S/c20-15-2-1-13(14-5-10-25-12-14)11-16(15)22-19(24)17-3-4-18(26-17)23-8-6-21-7-9-23/h1-5,10-12,21H,6-9,20H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411362
PNG
(US10385031, Compound 068)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C21H21FN4OS/c22-16-4-1-14(2-5-16)15-3-6-17(23)18(13-15)25-21(27)19-7-8-20(28-19)26-11-9-24-10-12-26/h1-8,13,24H,9-12,23H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411372
PNG
(US10385031, Compound 078)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cc(F)cc(F)c1
Show InChI InChI=1S/C22H21F2N5O/c23-17-9-16(10-18(24)12-17)14-1-3-19(25)20(11-14)28-22(30)15-2-4-21(27-13-15)29-7-5-26-6-8-29/h1-4,9-13,26H,5-8,25H2,(H,28,30)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411379
PNG
(US10385031, Compound 085)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N6O/c22-17-7-6-16(15-4-2-1-3-5-15)12-18(17)26-21(28)19-13-25-20(14-24-19)27-10-8-23-9-11-27/h1-7,12-14,23H,8-11,22H2,(H,26,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411383
PNG
(US10385031, Compound 089)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C20H21N7O/c21-16-2-1-15(14-3-5-22-6-4-14)11-17(16)26-20(28)18-12-25-19(13-24-18)27-9-7-23-8-10-27/h1-6,11-13,23H,7-10,21H2,(H,26,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411328
PNG
(US10385031, Compound 034)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)16-11-21-18(26-16)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411329
PNG
(US10385031, Compound 035)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc2nc(ccc2c1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C26H24FN5O/c27-21-6-1-17(2-7-21)18-3-8-22(28)24(16-18)31-26(33)20-4-9-23-19(15-20)5-10-25(30-23)32-13-11-29-12-14-32/h1-10,15-16,29H,11-14,28H2,(H,31,33)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411330
PNG
(US10385031, Compound 036)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C22H22FN5O/c23-18-5-1-15(2-6-18)16-3-7-19(24)20(13-16)27-22(29)17-4-8-21(26-14-17)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411339
PNG
(US10385031, Compound 045)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1cccnc1
Show InChI InChI=1S/C19H20N6OS/c20-15-4-3-13(14-2-1-5-22-11-14)10-16(15)24-18(26)17-12-23-19(27-17)25-8-6-21-7-9-25/h1-5,10-12,21H,6-9,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411341
PNG
(US10385031, Compound 047 | US10385031, Compound 04...)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5OS/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411341
PNG
(US10385031, Compound 047 | US10385031, Compound 04...)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5OS/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411344
PNG
(US10385031, Compound 050)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)18-21-11-16(26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411345
PNG
(US10385031, Compound 051)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-11-13)9-15(14)22-17(24)18-21-10-16(26-18)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411348
PNG
(US10385031, Compound 054)
Show SMILES CN1CCN(CC1)c1cnc(s1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C19H21N5O2S/c1-23-6-8-24(9-7-23)17-12-21-19(27-17)18(25)22-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-12H,6-9,20H2,1H3,(H,22,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411350
PNG
(US10385031, Compound 056)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-10-13)9-15(14)21-17(24)18-22-16(11-26-18)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,21,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411352
PNG
(US10385031, Compound 058)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)24-19(27)20-25-18(12-28-20)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411359
PNG
(US10385031, Compound 065)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C19H20N4O2S/c20-14-4-3-13(16-2-1-11-25-16)12-15(14)22-19(24)17-5-6-18(26-17)23-9-7-21-8-10-23/h1-6,11-12,21H,7-10,20H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411361
PNG
(US10385031, Compound 067)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C20H21N5OS/c21-16-2-1-15(14-5-7-22-8-6-14)13-17(16)24-20(26)18-3-4-19(27-18)25-11-9-23-10-12-25/h1-8,13,23H,9-12,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411374
PNG
(US10385031, Compound 080)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C21H23N5OS/c1-25-8-10-26(11-9-25)16-5-7-18(23-14-16)21(27)24-19-13-15(4-6-17(19)22)20-3-2-12-28-20/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411376
PNG
(US10385031, Compound 082)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C21H23N5O2/c1-25-8-10-26(11-9-25)16-5-7-18(23-14-16)21(27)24-19-13-15(4-6-17(19)22)20-3-2-12-28-20/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411331
PNG
(US10385031, Compound 037)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)18-12-24-20(28-18)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411335
PNG
(US10385031, Compound 041)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C19H21N5OS2/c1-12-19(24-8-6-21-7-9-24)27-18(22-12)17(25)23-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-11,21H,6-9,20H2,1H3,(H,23,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411339
PNG
(US10385031, Compound 045)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1cccnc1
Show InChI InChI=1S/C19H20N6OS/c20-15-4-3-13(14-2-1-5-22-11-14)10-16(15)24-18(26)17-12-23-19(27-17)25-8-6-21-7-9-25/h1-5,10-12,21H,6-9,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411350
PNG
(US10385031, Compound 056)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-10-13)9-15(14)21-17(24)18-22-16(11-26-18)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,21,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411361
PNG
(US10385031, Compound 067)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C20H21N5OS/c21-16-2-1-15(14-5-7-22-8-6-14)13-17(16)24-20(26)18-3-4-19(27-18)25-11-9-23-10-12-25/h1-8,13,23H,9-12,21H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411364
PNG
(US10385031, Compound 070)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H25N5O/c1-27-11-13-28(14-12-27)22-10-8-19(16-25-22)23(29)26-21-15-18(7-9-20(21)24)17-5-3-2-4-6-17/h2-10,15-16H,11-14,24H2,1H3,(H,26,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411367
PNG
(US10385031, Compound 073)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C21H22N6O/c22-17-6-4-15(18-3-1-2-8-24-18)13-19(17)26-21(28)16-5-7-20(25-14-16)27-11-9-23-10-12-27/h1-8,13-14,23H,9-12,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411369
PNG
(US10385031, Compound 075)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C21H23N5O2/c1-25-7-9-26(10-8-25)20-5-3-16(13-23-20)21(27)24-19-12-15(2-4-18(19)22)17-6-11-28-14-17/h2-6,11-14H,7-10,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411370
PNG
(US10385031, Compound 076)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccccc1F
Show InChI InChI=1S/C22H22FN5O/c23-18-4-2-1-3-17(18)15-5-7-19(24)20(13-15)27-22(29)16-6-8-21(26-14-16)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411375
PNG
(US10385031, Compound 081)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C21H22N6O/c22-17-6-4-15(18-3-1-2-8-24-18)13-20(17)26-21(28)19-7-5-16(14-25-19)27-11-9-23-10-12-27/h1-8,13-14,23H,9-12,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411381
PNG
(US10385031, Compound 087)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C19H20N6O2/c20-14-4-3-13(17-2-1-9-27-17)10-15(14)24-19(26)16-11-23-18(12-22-16)25-7-5-21-6-8-25/h1-4,9-12,21H,5-8,20H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411382
PNG
(US10385031, Compound 088)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C19H20N6O2/c20-15-2-1-13(14-3-8-27-12-14)9-16(15)24-19(26)17-10-23-18(11-22-17)25-6-4-21-5-7-25/h1-3,8-12,21H,4-7,20H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411330
PNG
(US10385031, Compound 036)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C22H22FN5O/c23-18-5-1-15(2-6-18)16-3-7-19(24)20(13-16)27-22(29)17-4-8-21(26-14-17)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411336
PNG
(US10385031, Compound 042)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C19H21N5O2S/c1-12-19(24-8-6-21-7-9-24)27-18(22-12)17(25)23-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-11,21H,6-9,20H2,1H3,(H,23,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411346
PNG
(US10385031, Compound 052)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C19H20N6OS/c20-15-2-1-14(13-3-5-21-6-4-13)11-16(15)24-18(26)19-23-12-17(27-19)25-9-7-22-8-10-25/h1-6,11-12,22H,7-10,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411346
PNG
(US10385031, Compound 052)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C19H20N6OS/c20-15-2-1-14(13-3-5-21-6-4-13)11-16(15)24-18(26)19-23-12-17(27-19)25-9-7-22-8-10-25/h1-6,11-12,22H,7-10,20H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411347
PNG
(US10385031, Compound 053)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)20-24-12-18(28-20)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411348
PNG
(US10385031, Compound 054)
Show SMILES CN1CCN(CC1)c1cnc(s1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C19H21N5O2S/c1-23-6-8-24(9-7-23)17-12-21-19(27-17)18(25)22-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-12H,6-9,20H2,1H3,(H,22,25)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411352
PNG
(US10385031, Compound 058)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)24-19(27)20-25-18(12-28-20)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411352
PNG
(US10385031, Compound 058)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)24-19(27)20-25-18(12-28-20)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411358
PNG
(US10385031, Compound 064)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N4OS/c22-17-7-6-16(15-4-2-1-3-5-15)14-18(17)24-21(26)19-8-9-20(27-19)25-12-10-23-11-13-25/h1-9,14,23H,10-13,22H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411360
PNG
(US10385031, Compound 066)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C19H20N4O2S/c20-15-2-1-13(14-5-10-25-12-14)11-16(15)22-19(24)17-3-4-18(26-17)23-8-6-21-7-9-23/h1-5,10-12,21H,6-9,20H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411362
PNG
(US10385031, Compound 068)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C21H21FN4OS/c22-16-4-1-14(2-5-16)15-3-6-17(23)18(13-15)25-21(27)19-7-8-20(28-19)26-11-9-24-10-12-26/h1-8,13,24H,9-12,23H2,(H,25,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411368
PNG
(US10385031, Compound 074)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C21H23N5O2/c1-25-8-10-26(11-9-25)20-7-5-16(14-23-20)21(27)24-18-13-15(4-6-17(18)22)19-3-2-12-28-19/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411371
PNG
(US10385031, Compound 077)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cccc(F)c1
Show InChI InChI=1S/C22H22FN5O/c23-18-3-1-2-15(12-18)16-4-6-19(24)20(13-16)27-22(29)17-5-7-21(26-14-17)28-10-8-25-9-11-28/h1-7,12-14,25H,8-11,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411377
PNG
(US10385031, Compound 083)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C21H23N5O2/c1-25-7-9-26(10-8-25)17-3-5-19(23-13-17)21(27)24-20-12-15(2-4-18(20)22)16-6-11-28-14-16/h2-6,11-14H,7-10,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411384
PNG
(US10385031, Compound 090)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C21H21FN6O/c22-16-4-1-14(2-5-16)15-3-6-17(23)18(11-15)27-21(29)19-12-26-20(13-25-19)28-9-7-24-8-10-28/h1-6,11-13,24H,7-10,23H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411384
PNG
(US10385031, Compound 090)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C21H21FN6O/c22-16-4-1-14(2-5-16)15-3-6-17(23)18(11-15)27-21(29)19-12-26-20(13-25-19)28-9-7-24-8-10-28/h1-6,11-13,24H,7-10,23H2,(H,27,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411340
PNG
(US10385031, Compound 046)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-11-13)9-15(14)22-17(24)16-10-21-18(26-16)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411341
PNG
(US10385031, Compound 047 | US10385031, Compound 04...)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C20H21N5OS/c21-16-7-6-15(14-4-2-1-3-5-14)12-17(16)24-19(26)18-13-23-20(27-18)25-10-8-22-9-11-25/h1-7,12-13,22H,8-11,21H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411358
PNG
(US10385031, Compound 064)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N4OS/c22-17-7-6-16(15-4-2-1-3-5-15)14-18(17)24-21(26)19-8-9-20(27-19)25-12-10-23-11-13-25/h1-9,14,23H,10-13,22H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411365
PNG
(US10385031, Compound 071)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C21H23N5OS/c1-25-8-10-26(11-9-25)20-7-5-16(14-23-20)21(27)24-18-13-15(4-6-17(18)22)19-3-2-12-28-19/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411366
PNG
(US10385031, Compound 072)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cccnc1
Show InChI InChI=1S/C21H22N6O/c22-18-5-3-15(16-2-1-7-24-13-16)12-19(18)26-21(28)17-4-6-20(25-14-17)27-10-8-23-9-11-27/h1-7,12-14,23H,8-11,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411367
PNG
(US10385031, Compound 073)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C21H22N6O/c22-17-6-4-15(18-3-1-2-8-24-18)13-19(17)26-21(28)16-5-7-20(25-14-16)27-11-9-23-10-12-27/h1-8,13-14,23H,9-12,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411369
PNG
(US10385031, Compound 075)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C21H23N5O2/c1-25-7-9-26(10-8-25)20-5-3-16(13-23-20)21(27)24-19-12-15(2-4-18(19)22)17-6-11-28-14-17/h2-6,11-14H,7-10,22H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411371
PNG
(US10385031, Compound 077)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cccc(F)c1
Show InChI InChI=1S/C22H22FN5O/c23-18-3-1-2-15(12-18)16-4-6-19(24)20(13-16)27-22(29)17-5-7-21(26-14-17)28-10-8-25-9-11-28/h1-7,12-14,25H,8-11,24H2,(H,27,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411373
PNG
(US10385031, Compound 079)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H25N5O/c1-27-11-13-28(14-12-27)19-8-10-21(25-16-19)23(29)26-22-15-18(7-9-20(22)24)17-5-3-2-4-6-17/h2-10,15-16H,11-14,24H2,1H3,(H,26,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411379
PNG
(US10385031, Compound 085)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N6O/c22-17-7-6-16(15-4-2-1-3-5-15)12-18(17)26-21(28)19-13-25-20(14-24-19)27-10-8-23-9-11-27/h1-7,12-14,23H,8-11,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411380
PNG
(US10385031, Compound 086)
Show SMILES CN1CCN(CC1)c1cnc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C20H22N6OS/c1-25-6-8-26(9-7-25)19-13-22-17(12-23-19)20(27)24-16-11-14(4-5-15(16)21)18-3-2-10-28-18/h2-5,10-13H,6-9,21H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411383
PNG
(US10385031, Compound 089)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C20H21N7O/c21-16-2-1-15(14-3-5-22-6-4-14)11-17(16)26-20(28)18-12-25-19(13-24-18)27-9-7-23-8-10-27/h1-6,11-13,23H,7-10,21H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411332
PNG
(US10385031, Compound 038)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C22H22FN5O/c23-17-4-1-15(2-5-17)16-3-7-19(24)21(13-16)27-22(29)20-8-6-18(14-26-20)28-11-9-25-10-12-28/h1-8,13-14,25H,9-12,24H2,(H,27,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411338
PNG
(US10385031, Compound 044)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C19H20N6OS/c20-14-5-4-13(15-3-1-2-6-22-15)11-16(14)24-18(26)17-12-23-19(27-17)25-9-7-21-8-10-25/h1-6,11-12,21H,7-10,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411338
PNG
(US10385031, Compound 044)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C19H20N6OS/c20-14-5-4-13(15-3-1-2-6-22-15)11-16(14)24-18(26)17-12-23-19(27-17)25-9-7-21-8-10-25/h1-6,11-12,21H,7-10,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411340
PNG
(US10385031, Compound 046)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccoc1
Show InChI InChI=1S/C18H19N5O2S/c19-14-2-1-12(13-3-8-25-11-13)9-15(14)22-17(24)16-10-21-18(26-16)23-6-4-20-5-7-23/h1-3,8-11,20H,4-7,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411353
PNG
(US10385031, Compound 059)
Show SMILES Nc1ccc(cc1NC(=O)c1csc(n1)N1CCNCC1)-c1cccs1
Show InChI InChI=1S/C18H19N5OS2/c19-13-4-3-12(16-2-1-9-25-16)10-14(13)21-17(24)15-11-26-18(22-15)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,21,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411359
PNG
(US10385031, Compound 065)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C19H20N4O2S/c20-14-4-3-13(16-2-1-11-25-16)12-15(14)22-19(24)17-5-6-18(26-17)23-9-7-21-8-10-23/h1-6,11-12,21H,7-10,20H2,(H,22,24)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411364
PNG
(US10385031, Compound 070)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H25N5O/c1-27-11-13-28(14-12-27)22-10-8-19(16-25-22)23(29)26-21-15-18(7-9-20(21)24)17-5-3-2-4-6-17/h2-10,15-16H,11-14,24H2,1H3,(H,26,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411371
PNG
(US10385031, Compound 077)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cccc(F)c1
Show InChI InChI=1S/C22H22FN5O/c23-18-3-1-2-15(12-18)16-4-6-19(24)20(13-16)27-22(29)17-5-7-21(26-14-17)28-10-8-25-9-11-28/h1-7,12-14,25H,8-11,24H2,(H,27,29)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411373
PNG
(US10385031, Compound 079)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C23H25N5O/c1-27-11-13-28(14-12-27)19-8-10-21(25-16-19)23(29)26-22-15-18(7-9-20(22)24)17-5-3-2-4-6-17/h2-10,15-16H,11-14,24H2,1H3,(H,26,29)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411375
PNG
(US10385031, Compound 081)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(cn1)N1CCNCC1)-c1ccccn1
Show InChI InChI=1S/C21H22N6O/c22-17-6-4-15(18-3-1-2-8-24-18)13-20(17)26-21(28)19-7-5-16(14-25-19)27-11-9-23-10-12-27/h1-8,13-14,23H,9-12,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411377
PNG
(US10385031, Compound 083)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C21H23N5O2/c1-25-7-9-26(10-8-25)17-3-5-19(23-13-17)21(27)24-20-12-15(2-4-18(20)22)16-6-11-28-14-16/h2-6,11-14H,7-10,22H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411329
PNG
(US10385031, Compound 035)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc2nc(ccc2c1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C26H24FN5O/c27-21-6-1-17(2-7-21)18-3-8-22(28)24(16-18)31-26(33)20-4-9-23-19(15-20)5-10-25(30-23)32-13-11-29-12-14-32/h1-10,15-16,29H,11-14,28H2,(H,31,33)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411331
PNG
(US10385031, Compound 037)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1ccc(F)cc1
Show InChI InChI=1S/C20H20FN5OS/c21-15-4-1-13(2-5-15)14-3-6-16(22)17(11-14)25-19(27)18-12-24-20(28-18)26-9-7-23-8-10-26/h1-6,11-12,23H,7-10,22H2,(H,25,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411335
PNG
(US10385031, Compound 041)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C19H21N5OS2/c1-12-19(24-8-6-21-7-9-24)27-18(22-12)17(25)23-15-11-13(4-5-14(15)20)16-3-2-10-26-16/h2-5,10-11,21H,6-9,20H2,1H3,(H,23,25)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411337
PNG
(US10385031, Compound 043)
Show SMILES Cc1nc(sc1N1CCNCC1)C(=O)Nc1cc(ccc1N)-c1ccoc1
Show InChI InChI=1S/C19H21N5O2S/c1-12-19(24-7-5-21-6-8-24)27-18(22-12)17(25)23-16-10-13(2-3-15(16)20)14-4-9-26-11-14/h2-4,9-11,21H,5-8,20H2,1H3,(H,23,25)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411339
PNG
(US10385031, Compound 045)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(s1)N1CCNCC1)-c1cccnc1
Show InChI InChI=1S/C19H20N6OS/c20-15-4-3-13(14-2-1-5-22-11-14)10-16(15)24-18(26)17-12-23-19(27-17)25-8-6-21-7-9-25/h1-5,10-12,21H,6-9,20H2,(H,24,26)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411344
PNG
(US10385031, Compound 050)
Show SMILES Nc1ccc(cc1NC(=O)c1ncc(s1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)22-17(24)18-21-11-16(26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,22,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411349
PNG
(US10385031, Compound 055)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C18H19N5O2S/c19-13-4-3-12(15-2-1-9-25-15)10-14(13)21-17(24)18-22-16(11-26-18)23-7-5-20-6-8-23/h1-4,9-11,20H,5-8,19H2,(H,21,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411351
PNG
(US10385031, Compound 057)
Show SMILES Nc1ccc(cc1NC(=O)c1nc(cs1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C19H20N6OS/c20-15-2-1-14(13-3-5-21-6-4-13)11-16(15)23-18(26)19-24-17(12-27-19)25-9-7-22-8-10-25/h1-6,11-12,22H,7-10,20H2,(H,23,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411363
PNG
(US10385031, Compound 069)
Show SMILES Nc1ccc(cc1NC(=O)c1cc(cs1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N4OS/c22-18-7-6-16(15-4-2-1-3-5-15)12-19(18)24-21(26)20-13-17(14-27-20)25-10-8-23-9-11-25/h1-7,12-14,23H,8-11,22H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411365
PNG
(US10385031, Compound 071)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1cccs1
Show InChI InChI=1S/C21H23N5OS/c1-25-8-10-26(11-9-25)20-7-5-16(14-23-20)21(27)24-18-13-15(4-6-17(18)22)19-3-2-12-28-19/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411366
PNG
(US10385031, Compound 072)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cccnc1
Show InChI InChI=1S/C21H22N6O/c22-18-5-3-15(16-2-1-7-24-13-16)12-19(18)26-21(28)17-4-6-20(25-14-17)27-10-8-23-9-11-27/h1-7,12-14,23H,8-11,22H2,(H,26,28)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 3


(Homo sapiens (Human))
BDBM411368
PNG
(US10385031, Compound 074)
Show SMILES CN1CCN(CC1)c1ccc(cn1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C21H23N5O2/c1-25-8-10-26(11-9-25)20-7-5-16(14-23-20)21(27)24-18-13-15(4-6-17(18)22)19-3-2-12-28-19/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411376
PNG
(US10385031, Compound 082)
Show SMILES CN1CCN(CC1)c1ccc(nc1)C(=O)Nc1cc(ccc1N)-c1ccco1
Show InChI InChI=1S/C21H23N5O2/c1-25-8-10-26(11-9-25)16-5-7-18(23-14-16)21(27)24-19-13-15(4-6-17(19)22)20-3-2-12-28-20/h2-7,12-14H,8-11,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411381
PNG
(US10385031, Compound 087)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccco1
Show InChI InChI=1S/C19H20N6O2/c20-14-4-3-13(17-2-1-9-27-17)10-15(14)24-19(26)16-11-23-18(12-22-16)25-7-5-21-6-8-25/h1-4,9-12,21H,5-8,20H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411383
PNG
(US10385031, Compound 089)
Show SMILES Nc1ccc(cc1NC(=O)c1cnc(cn1)N1CCNCC1)-c1ccncc1
Show InChI InChI=1S/C20H21N7O/c21-16-2-1-15(14-3-5-22-6-4-14)11-17(16)26-20(28)18-12-25-19(13-24-18)27-9-7-23-8-10-27/h1-6,11-13,23H,7-10,21H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411363
PNG
(US10385031, Compound 069)
Show SMILES Nc1ccc(cc1NC(=O)c1cc(cs1)N1CCNCC1)-c1ccccc1
Show InChI InChI=1S/C21H22N4OS/c22-18-7-6-16(15-4-2-1-3-5-15)12-19(18)24-21(26)20-13-17(14-27-20)25-10-8-23-9-11-25/h1-7,12-14,23H,8-11,22H2,(H,24,26)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 2


(Homo sapiens (Human))
BDBM411366
PNG
(US10385031, Compound 072)
Show SMILES Nc1ccc(cc1NC(=O)c1ccc(nc1)N1CCNCC1)-c1cccnc1
Show InChI InChI=1S/C21H22N6O/c22-18-5-3-15(16-2-1-7-24-13-16)12-19(18)26-21(28)17-4-6-20(25-14-17)27-10-8-23-9-11-27/h1-7,12-14,23H,8-11,22H2,(H,26,28)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<1.00E+3n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%